AAUM (Average Assets Under Management) of ₹322.85 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 66.1% | 69.1% | ▲ +3.0% |
| Healthcare Services | 28.4% | 25.0% | ▼ -3.3% |
| N.A. | 1.0% | 1.0% | ● 0.0% |
| Insurance | 1.0% | 0.9% | ▼ -0.1% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.1% | 67.7% | ▼ -1.4% |
| Healthcare Services | 25.0% | 23.9% | ▼ -1.2% |
| N.A. | 1.0% | 1.2% | ▲ +0.2% |
| Insurance | 0.9% | 0.8% | ● -0.1% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Shilpa Medicare Ltd ₹13.61 Cr |
Pharmaceuticals & Biotechnology | 3.72% | 4.17% | +0.45% |
| 2 | Lupin Limited ₹14.21 Cr |
Pharmaceuticals & Biotechnology | 3.96% | 4.35% | +0.39% |
| 3 | Novartis India Limited ₹6.13 Cr |
Pharmaceuticals & Biotechnology | 1.50% | 1.88% | +0.38% |
| 4 | Dr. Reddy's Laboratories Limited ₹12.33 Cr |
Pharmaceuticals & Biotechnology | 3.48% | 3.78% | +0.30% |
| 5 | Sai Parenterals Limited ₹3.75 Cr |
N.A. | 0.95% | 1.15% | +0.20% |
| 6 | Narayana Hrudayalaya Limited ₹8.96 Cr |
Healthcare Services | 2.59% | 2.74% | +0.15% |
| 7 | Apollo Hospitals Enterprise Limited ₹18.78 Cr |
Healthcare Services | 5.64% | 5.75% | +0.11% |
| 8 | Rainbow Childrens Medicare Limited ₹7.23 Cr |
Healthcare Services | 2.13% | 2.21% | +0.08% |
| 9 | Sai Life Sciences Limited ₹3.81 Cr |
Pharmaceuticals & Biotechnology | 1.10% | 1.17% | +0.07% |
| 10 | Gland Pharma Limited ₹10.15 Cr |
Pharmaceuticals & Biotechnology | 3.05% | 3.11% | +0.06% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited ₹31.79 Cr |
Pharmaceuticals & Biotechnology | 10.48% | 9.74% | -0.74% |
| 2 | Global Health Limited ₹6.14 Cr |
Healthcare Services | 2.45% | 1.88% | -0.57% |
| 3 | Max Healthcare Institute Limited ₹17.20 Cr |
Healthcare Services | 5.81% | 5.27% | -0.54% |
| 4 | Ajanta Pharma Limited ₹3.98 Cr |
Pharmaceuticals & Biotechnology | 1.74% | 1.22% | -0.52% |
| 5 | Healthcare Global Enterprises Limited ₹4.33 Cr |
Healthcare Services | 1.66% | 1.33% | -0.33% |
| 6 | Pfizer Limited ₹5.04 Cr |
Pharmaceuticals & Biotechnology | 1.84% | 1.54% | -0.30% |
| 7 | GlaxoSmithKline Pharmaceuticals Limited ₹11.08 Cr |
Pharmaceuticals & Biotechnology | 3.68% | 3.39% | -0.29% |
| 8 | Alivus Life Sciences ₹3.75 Cr |
Pharmaceuticals & Biotechnology | 1.36% | 1.15% | -0.21% |
| 9 | Cipla Limited ₹20.19 Cr |
Pharmaceuticals & Biotechnology | 6.38% | 6.18% | -0.20% |
| 10 | Jubilant Pharmova Limited ₹4.12 Cr |
Pharmaceuticals & Biotechnology | 1.46% | 1.26% | -0.20% |
35 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹31.79 Cr |
Pharmaceuticals & Biotechnology |
9.74%
|
|
| 2 |
₹20.19 Cr |
Pharmaceuticals & Biotechnology |
6.18%
|
|
| 3 |
₹18.78 Cr |
Healthcare Services |
5.75%
|
|
| 4 |
₹17.20 Cr |
Healthcare Services |
5.27%
|
|
| 5 |
₹14.21 Cr |
Pharmaceuticals & Biotechnology |
4.35%
|
|
| 6 |
₹13.94 Cr |
Pharmaceuticals & Biotechnology |
4.27%
|
|
| 7 |
₹13.61 Cr |
Pharmaceuticals & Biotechnology |
4.17%
|
|
| 8 |
₹13.38 Cr |
Pharmaceuticals & Biotechnology |
4.10%
|
|
| 9 |
₹12.33 Cr |
Pharmaceuticals & Biotechnology |
3.78%
|
|
| 10 |
₹11.08 Cr |
Pharmaceuticals & Biotechnology |
3.39%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.